Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Service & Compliance Process This is a Procurement Facilitation Service
The pharmacist will discuss your symptoms and medical background
These can include nausea, vomiting, diarrhea, or constipation
At six months, patients treated with tirzepatide experienced greater average weight loss than those treated with semaglutide (-11.15% vs -8.83%), with more patients reaching clinically meaningful weight-loss thresholds
Of the included papers, 16 were randomised control trials (RCT), five were single arm interventional studies, one was a non-randomised comparative interventional study and one was a phase IV clinical trial
Maintenance Phase : Upon reaching weight goals, a lower dose helps in maintaining progress over time
US$ 24.50
US$ 26.65
US$ 28.09
